Fierce Biotech April 11, 2024
Conor Hale

Steris has signed a pact to sell its dentistry business to the private equity firm Peak Rock Capital, through a $787.5 million transaction aimed at helping to pay down the company’s debts left from its previous multi-billion-dollar M&A outlays.

Collectively known as the HuFriedyGroup, the 1,500-employee international division manufactures dental instruments, infection prevention products and patient sedation systems, including the long-time brands of Hu-Friedy, Crosstex, Omnia and Accutron.

Steris said it expects to close the deal by the end of June. During the 2023 calendar year, the company said the Chicago-based enterprise brought in $407 million in revenues and $86 million in operating income.

“Since acquiring our dental segment through the Cantel acquisition, we have focused on deploying lean manufacturing...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Medical Devices, Trends
How private investment can improve senior-housing options
How Crunchbase AI Is Forecasting Unicorns With 95% Accuracy
AI competition is eating the world
Private equity firm to buy Walgreens for $10B, report says
Flosonics Medical Secures C$7.5M to Scale Wearable Ultrasound Tech | StartUp Health Insights: Week of Mar 4, 2025

Share This Article